Your direction sounds great—but how well can $4M move the needle there? How well can genesmith move the needle with his time and energy?
I think you’re correct about the cheapest/easist strategy in general, but completely off in regards to marginal advantages.
Major labs will already be pouring massive amounts of money and human capital into direct AI alignment and using AIs to align AGI if we get to a freeze, and the further along in capabilities we get the more impactful such research would be.
Genesmith’s strategy benefits much more from starting now and has way less human talent and capital involved, hence higher marginal value
Your direction sounds great—but how well can $4M move the needle there? How well can genesmith move the needle with his time and energy?
I think you’re correct about the cheapest/easist strategy in general, but completely off in regards to marginal advantages.
Major labs will already be pouring massive amounts of money and human capital into direct AI alignment and using AIs to align AGI if we get to a freeze, and the further along in capabilities we get the more impactful such research would be.
Genesmith’s strategy benefits much more from starting now and has way less human talent and capital involved, hence higher marginal value